HealthyPhase 4NCT01427426
Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?
A Phase 4 study testing All Greens in people with Healthy, run by University of British Columbia at 1 site in Canada.
Trial summary
Factors Group is a producer of nutritional supplements. This study aims to determine whether one of their products improves the energy and sense of well-being in individuals who consume it. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- All Greens
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 120 participants
- Where
- 1 siteCanada
- Study dates
- Jan 2012to Jun 2012
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Not taking any other nutritional supplement (including fish oils, vitamins...) or be willing to discontinue use for duration of study
Who cannot join
- Medical conditions such as diabetes, asthma, cancer, cardiovascular disease, high blood pressure, celiac disease, a history of kidney stones or psychiatric illness.
- Currently taking antidepressants, anticoagulant or other medications that may interact with the nutritional supplement.
- Unable to provide informed consent
- Women who are pregnant or breastfeeding
Trial locations and contacts
1 site in 1 country.
Canada1 site
University of British Columbia
Vancouver, British Columbia, V6T 1Z4
About this study
Factors Group is a producer of nutritional supplements. This study aims to determine whether one of their products improves the energy and sense of well-being in individuals who consume it. Interested subjects will complete a 1 week lead-in phase where they will be asked to consume a placebo daily to see if they are a good fit for the study. After the lead-in phase, subjects will be randomized to take either All Greens or a different placebo for 12 weeks. The investigators expect All Greens to have better results than the placebo, but subjects will not know which supplement they are taking. The primary outcome is a score on a questionnaire of well being.
Read the detailed description
PURPOSE To conduct a study to determine the potential benefits of All Greens.
HYPOTHESIS Our primary hypothesis is that a greater proportion of participants on All Greens will score higher on the subjective scores of vitality and energy, as measured by our validated survey, than those consuming the control formulation.
JUSTIFICATION All Greens is a mixture of organic alfalfa powder, barley, wheat grass juice powder, lycopene, cranberry juice extract, rosehips, grapeseed phytosomes, soya extract, Acidophilus, bromelain, apple pectin, and other ingredients. All Greens is a well-balanced phytonutrient formula that nourishes, energizes, cleanses and acts as a whole body tonic. Recently, Boon et al (2004) have published results demonstrating some clinical benefits of consuming Greens+, a product similar to All Greens. After 12 weeks, women randomized to consume Greens+ scored marginally higher on subjective scores on Vitality and significantly higher on Energy than those consuming a placebo group (Boon, 2004). However, limitations of this study such as incomplete blinding and a high drop-out rate limit the veracity of the findings.
OBJECTIVES To determine if 12 weeks of consumption of All Greens increases vitality, energy, and perception of well-being compared to consumption of a placebo in adult women and men (18-45 y).
RESEARCH METHOD The investigators aim to recruit 120 people (18-45 y) through advertisements and word of mouth. In a lead-in phase, subjects will be asked to consume an 'initiation drink' daily for a week. The purpose of this is to identify those subjects who are unlikely to complete the study so they can be excluded before randomization, in order to minimize the dropout rate. The lead-in product will be composed primarily of rice flour, with other ingredients added to make it comparable to the All Greens and control formulation.
Participants remaining after the week lead-in phase week will be asked to attend a morning clinic at the university. Height and weight will be recorded, health and demographic information will be collected by questionnaire, and outcome measure questionnaires will be completed. Participants will be randomized to All Greens or the control formulation. Subjects will be instructed to record any side effects or adverse events in a study diary. At 6 weeks, study staff will phone participants, to check on progress.
Twelve weeks after randomization, participants will be asked to return to clinic to repeat the outcome measure questionnaires. Compliance will be assessed by weighing returned supplements and by patient diary. Adverse events will be recorded in the diaries. If patients withdraw from the study they will still be encouraged to return at 12 weeks to complete the outcome measures to allow for intent-to-treat analysis.
SAMPLE SIZE The sample size estimate is based on the primary outcome. The mean score on the vitality subscale of the SF-36 in a large study of women was 65 with a SD of 18. A ten-point change in the SF-36 vitality sub-scale can be considered a "moderate" effect that is clinically and socially relevant. Assuming 80% power, P-value of 0.05, an SD of 18, a correlation between baseline and follow-up measures of at least R=0.5, 50 subjects per treatment group would be needed to detect a 5 point difference between the groups. Assuming 20% attrition 120 subjects randomized would be required.
STATISTICAL ANALYSIS Differences in outcomes measures at twelve weeks will be assessed by multiple regression analysis with adjustment for baseline values and other predetermined factors (i.e. last menstrual period, oral contraceptive use).
- Conditions
- Healthy
- Being tested
- All Greens, Control Formulation
- Keywords
- Health, Vitality, Well-being, Nutritional Supplement, Phytonutrient, Greens
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
All GreensDietary supplement
All Greens is a mixture of organic alfalfa powder, barley, wheat grass juice powder, lycopene, cranberry juice extract, rosehips, grapeseed phytosomes, soya extract, Acidophilus, bromelain, apple pectin, and other ingredients. All Greens is approved by Health Canada and available to the public for purchase.
Control FormulationOther
The Control Formulation is a rice-flour based product that has been designed to mimic the All Greens in appearance and taste.
| Study group | Role | What they receive |
|---|---|---|
| All Greens | Experimental | Subjects will consume the All Greens product daily. Product is prepared by mixing with either water, juice or in a smoothie. Receives: Dietary Supplement: All Greens |
| Control formulation | Sham comparator | Subjects will consume a product of similar consistency and comparable taste that does not have the same healthy ingredients as the All Greens. Receives: Other: Control Formulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in score on the Short-Form 36 (SF-36)
The Short Form-36 (SF-36) is a validated, multi-purpose, short-form health survey that is a generic measure of health status/quality of life. It provides an overall measure of physical and mental health, as well as eight subscale profiles, of which three were considered to be relevant for this study: general health, vitality, and mental health. The SF-36 is licensed by the company QualityMetric.
Measured: Baseline and Study End (12 weeks after randomization)
Secondary outcomes (3)
Change in scores on 10 cm Visual Analogue Scales (VAS)
VAS scores will assess energy levels and sense of well being of subjects.
Measured: Randomization and 12 weeks (study end)
Number of participants who report side effects
Date, time, description, duration, frequency and severity (on a 5 point scale), of side effects will be recorded by the participant by use of a study diary.
Measured: From enrollment to 13 weeks (study end)
Number of unused supplement packets
Compliance will be assessed by counting returned supplement packets as well as by review of the subject's study diary.
Measured: Enrollment to 13 weeks (study end)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2011 (estimated)
- Study startJan 2012
- Primary completionMay 2012
- Study completionJun 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 120 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- Factors Group of Nutritional Companies Inc., QualityMetrics
- Responsible party
- Sponsor
- Investigators
- Timothy J Green, PhD, Principal investigator, University of British Columbia, Department of Food, Nutrition and Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01427426
- Sponsor's protocol ID
- H11-00426
- Status last verified
- Mar 2014
- First submitted
- 5 Aug 2011
- Last updated
- 17 Mar 2014
- Results posted
- No
- Data monitoring committee
- No
Publications
Boon H, Clitheroe J, Forte T. Effects of greens+: a randomized, controlled trial. Can J Diet Pract Res. 2004 Summer;65(2):66-71. doi: 10.3148/65.2.2004.66.
PubMed 15217524
Study at a glance
From the registry record, last updated by the sponsor on 17 Mar 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?
- ClinicalTrials.gov ID
- NCT01427426
- Acronym / sponsor ID
- H11-00426
- Conditions
- Healthy
- Keywords
- Health, Vitality, Well-being, Nutritional Supplement, Phytonutrient, Greens
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (actual)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- Factors Group of Nutritional Companies Inc., QualityMetrics
- Study start
- Jan 2012
- Primary completion
- May 2012 (actual)
- Study completion
- Jun 2012 (actual)
- First posted
- 1 Sep 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Factors Group is a producer of nutritional supplements. This study aims to determine whether one of their products improves the energy and sense of well-being in individuals who consume it. Interested subjects will complete a 1 week lead-in phase where they will be asked to consume a placebo daily to see if they are a good fit for the study. After the lead-in phase, subjects will be randomized to take either All Greens or a different placebo for 12 weeks. The investigators expect All Greens to have better results than the placebo, but subjects will not know which supplement they are taking. The primary outcome is a score on a questionnaire of well being.
Detailed description
PURPOSE To conduct a study to determine the potential benefits of All Greens.
HYPOTHESIS Our primary hypothesis is that a greater proportion of participants on All Greens will score higher on the subjective scores of vitality and energy, as measured by our validated survey, than those consuming the control formulation.
JUSTIFICATION All Greens is a mixture of organic alfalfa powder, barley, wheat grass juice powder, lycopene, cranberry juice extract, rosehips, grapeseed phytosomes, soya extract, Acidophilus, bromelain, apple pectin, and other ingredients. All Greens is a well-balanced phytonutrient formula that nourishes, energizes, cleanses and acts as a whole body tonic. Recently, Boon et al (2004) have published results demonstrating some clinical benefits of consuming Greens+, a product similar to All Greens. After 12 weeks, women randomized to consume Greens+ scored marginally higher on subjective scores on Vitality and significantly higher on Energy than those consuming a placebo group (Boon, 2004). However, limitations of this study such as incomplete blinding and a high drop-out rate limit the veracity of the findings.
OBJECTIVES To determine if 12 weeks of consumption of All Greens increases vitality, energy, and perception of well-being compared to consumption of a placebo in adult women and men (18-45 y).
RESEARCH METHOD The investigators aim to recruit 120 people (18-45 y) through advertisements and word of mouth. In a lead-in phase, subjects will be asked to consume an 'initiation drink' daily for a week. The purpose of this is to identify those subjects who are unlikely to complete the study so they can be excluded before randomization, in order to minimize the dropout rate. The lead-in product will be composed primarily of rice flour, with other ingredients added to make it comparable to the All Greens and control formulation.
Participants remaining after the week lead-in phase week will be asked to attend a morning clinic at the university. Height and weight will be recorded, health and demographic information will be collected by questionnaire, and outcome measure questionnaires will be completed. Participants will be randomized to All Greens or the control formulation. Subjects will be instructed to record any side effects or adverse events in a study diary. At 6 weeks, study staff will phone participants, to check on progress.
Twelve weeks after randomization, participants will be asked to return to clinic to repeat the outcome measure questionnaires. Compliance will be assessed by weighing returned supplements and by patient diary. Adverse events will be recorded in the diaries. If patients withdraw from the study they will still be encouraged to return at 12 weeks to complete the outcome measures to allow for intent-to-treat analysis.
SAMPLE SIZE The sample size estimate is based on the primary outcome. The mean score on the vitality subscale of the SF-36 in a large study of women was 65 with a SD of 18. A ten-point change in the SF-36 vitality sub-scale can be considered a "moderate" effect that is clinically and socially relevant. Assuming 80% power, P-value of 0.05, an SD of 18, a correlation between baseline and follow-up measures of at least R=0.5, 50 subjects per treatment group would be needed to detect a 5 point difference between the groups. Assuming 20% attrition 120 subjects randomized would be required.
STATISTICAL ANALYSIS Differences in outcomes measures at twelve weeks will be assessed by multiple regression analysis with adjustment for baseline values and other predetermined factors (i.e. last menstrual period, oral contraceptive use).
Study design
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| All Greens | Experimental | Dietary Supplement: All GreensSubjects will consume the All Greens product daily. Product is prepared by mixing with either water, juice or in a smoothie. |
| Control formulation | Sham comparator | Other: Control FormulationSubjects will consume a product of similar consistency and comparable taste that does not have the same healthy ingredients as the All Greens. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Not taking any other nutritional supplement (including fish oils, vitamins...) or be willing to discontinue use for duration of study
Key exclusion criteria (4 listed)
- Medical conditions such as diabetes, asthma, cancer, cardiovascular disease, high blood pressure, celiac disease, a history of kidney stones or psychiatric illness.
- Currently taking antidepressants, anticoagulant or other medications that may interact with the nutritional supplement.
- Unable to provide informed consent
- Women who are pregnant or breastfeeding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| All GreensAll Greens is a mixture of organic alfalfa powder, barley, wheat grass juice powder, lycopene, cranberry juice extract, rosehips, grapeseed phytosomes, soya extract, Acidophilus, bromelain, apple pectin, and other ingredients. All Greens is approved by Health Canada and available to the public for purchase. | Dietary supplement | All Greens |
| Control FormulationThe Control Formulation is a rice-flour based product that has been designed to mimic the All Greens in appearance and taste. | Other | Control formulation |
Primary outcome
Change in score on the Short-Form 36 (SF-36)
Time frame: Baseline and Study End (12 weeks after randomization)
The Short Form-36 (SF-36) is a validated, multi-purpose, short-form health survey that is a generic measure of health status/quality of life. It provides an overall measure of physical and mental health, as well as eight subscale profiles, of which three were considered to be relevant for this study: general health, vitality, and mental health. The SF-36 is licensed by the company QualityMetric.
3 secondary outcomes
Change in scores on 10 cm Visual Analogue Scales (VAS)
Time frame: Randomization and 12 weeks (study end)
Number of participants who report side effects
Time frame: From enrollment to 13 weeks (study end)
Number of unused supplement packets
Time frame: Enrollment to 13 weeks (study end)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Mar 2014.
- Background: PubMed 15217524Boon H, Clitheroe J, Forte T. Effects of greens+: a randomized, controlled trial. Can J Diet Pract Res. 2004 Summer;65(2):66-71. doi: 10.3148/65.2.2004.66.
Related trials for Healthy
Not yet recruitingPhase 1
Dynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium Contrast
Healthy Volunteers
RecruitingObservational study
Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
Healthy Volunteers
Active, not recruitingPhase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
Healthy
Not yet recruitingObservational study
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Blood Donors, Apheresis
Recruiting
Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals
Fatty Acids, Omega-3, Fish Oils
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Timothy J Green, PhD principal investigator
University of British Columbia, Department of Food, Nutrition and Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing All Greens in people with Healthy, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in score on the Short-Form 36 (SF-36) (time frame: Baseline and Study End (12 weeks after randomization)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01427426, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2014.